NCT05392946 2026-04-21Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL StudyMayo ClinicPhase 1/2 Active not recruiting49 enrolled
NCT07463807 2026-04-13Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After TreatmentNational Cancer Institute (NCI)Phase 1/2 Not yet recruiting162 enrolled